| Literature DB >> 26728562 |
A S Smith1, S K Williams Avram1, A Cymerblit-Sabba1, J Song1, W S Young1.
Abstract
Social cognition enables individuals to understand others' intentions. Social memory is a necessary component of this process, for without it, subsequent encounters are devoid of any historical information. The CA2 area of the hippocampus, particularly the vasopressin 1b receptor (Avpr1b) expressed there, is necessary for memory formation. We used optogenetics to excite vasopressin terminals, originating from the hypothalamic paraventricular nucleus, in the CA2 of mice. This markedly enhanced their social memory if the stimulation occurred during memory acquisition, but not retrieval. This effect was blocked by an Avpr1b antagonist. Finally, this enhanced memory is resistant to the social distraction of an introduced second mouse, important for socially navigating populations of individuals. Our results indicate the CA2 can increase the salience of social signals. Targeted pharmacotherapy with Avpr1b agonists or deep brain stimulation of the CA2 are potential avenues of treatment for those with declining social memory as in various dementias.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26728562 PMCID: PMC4935650 DOI: 10.1038/mp.2015.189
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 15.992
Figure 1The AvpPVN→CA2 pathway is anatomically distinct
a, The diagram illustrating ST HSV-LS1L-WGA-CMV-GFP viral injections in the hippocampal CA2 and subsequent expression in the CA2 (fibers) and hypothalamic paraventricular nucleus (PVN, soma and fibers). b–c, Image and diagram of coronal sections show the expression of green fluorescent protein (GFP+, green) following a Cre-inducible HSV-GFP injection and vasopressin (AVP+, red) immunostaining in the PVN of AVP promoter-driven Cre (Avp-Cre) mice. Cell nuclei are stained with 4′,6-diamidino-2-phenylindole (DAPI, blue). d, Quantification of Avp+, GFP+, and GFP+ neurons that are Avp+ in the PVN reveal that a subset of Avp+ neurons express the viral GFP+ and therefore project to the CA2. Further, all GFP+ neurons co-express Avp+, indicating that the HSV-GFP selectively labeled Avp+ neurons (n = 3 sections from 4 mice). e–f, Image and diagram of coronal sections show that Avp fibers (labeled by expression of GFP+) projecting from the PVN innervate the CA2 and immediately adjacent CA3. Arrows are used to identify anatomical boundaries for the CA areas. g, Specifically, GFP+ fluorescence intensity, reported in arbitrary units (a.u.), is highest in the CA2, and to a lesser extent immediately adjacent CA3 (aCA3), compared to the surrounding regions, which include the distal CA3 (dCA3), CA1, parietal cortex (PCX), and somatosensory cortex (SCX). h, The schematic illustrates AAV2-DIO-EF1α-hChR2(H134R)-mCherry viral injections and optical stimulation, emitting at a 465-nm wavelength from a LED light, of AvpPVN→CA2 fibers. i–j, These are images of coronal sections showing expression of ChR2 fused to mCherry (ChR2+, red) in the PVN and CA2 of Avp-Cre mice. Arrows are used to identify anatomical boundaries for the CA areas. Cell nuclei are stained with DAPI (blue). Scale bars are labeled for all images.
Figure 2Activation of AvpPVN→CA2 neurons enhances social memory
a, The two-trial social recognition test included two five-minute exposures to social or object stimuli with concurrent optical stimulation (20-ms pulses of 465-nm light at 1.5mW mm−2). The retention interval was established at 2 hr. b, Behavioral data are from wild-type (WT, grey) and AVP promoter-driven Cre (Avp-Cre, white or blue) mice injected in the PVN with an adeno-associated virus containing a Cre-inducible ChR2-mCherry (AAV2-DIO-EF1α-hChR2(H134R)-mCherry) and implanted with optical fibers bilaterally in the CA2. Mice were exposed to an unfamiliar OVX female for 5 minutes and re-exposed to the original (Same ♀) or a novel (Novel ♀) female after a 2-hr retention interval. This same protocol was used for object recognition (Object). The optical stimulation was present (ON) or absent (OFF) for both trials. During the two-trial social recognition test, Avp-Cre mice (n = 7) with optical stimulation displayed decreased investigation during trial 2 of a mouse encountered in trial 1 (ANOVA: genotype X trial F(1,13) = 6.08, P < 0.05); no recognition was observed by WT (n = 8) or Avp-Cre under any other condition (ANOVA: genotype X trial F(1,13) < 1.21, P > 0.29). Mice did not habituate to multiple sessions of social recognition, observable by the similarity in Trial 1 sniffing behavior in the three social recognition conditions. Mice did display a social preference, sniffing social stimuli more during the acquisition trial then object stimuli. c, The percent change score for investigation was significantly decreased in optically stimulated Avp-Cre mice compared to WT mice (t(13) = 4.10, P < 0.001). No genotypic differences occurred in the change of investigation in any other condition (t(13) < 1.58, P > 0.13). d, The two-trial recognition test was repeated in Avp-Cre and WT mice as previously described under the Same ♀ condition; however, the optical stimulation was only present during the acquisition (Trial 1 ON) or retrieval (Trial 2 ON) trial. e, Avp-Cre (n = 7), but not WT (n = 9), decreased investigation behavior from trial 1 to trial 2 only when optical stimulation occurred during trial 1 (ANOVA: genotype X trial F(1,14) = 22.74, P < 0.0005); no effect occurred with trial 2 optical stimulation (ANOVA: genotype X trial F(1,14) = 1.24, P = 0.28). f, The investigation change score decreased in Avp-Cre mice receiving optical stimulation in trial 1 compared to WT mice (t(14) = 3.78, P < 0.005). No effect occurred from trial 2 optical stimulation (t(14) = 0.40, P = 0.69). g, The two-trial recognition test was repeated in Avp-Cre and WT mice as previously described under the Same ♀ condition with optical stimulation absent (OFF) or presented only during the acquisition trial (T1-ON). However, the retention interval was adjusted to 2 hr, 1 day, or 7 days. h, In this Extended retention recognition test, WT (n = 9) and Avp-Cre (n = 7) mice displayed similar investigation response in both trials without optical stimulation (ANOVA: genotype X trial F(1,14) = 1.24, P = 0.28). Avp-Cre mice receiving optical stimulation in trial 1 decreased investigation from trial 1 to trial 2 compared to WT mice, regardless of retention interval (ANOVA: genotype X trial F(1,14) > 14.00, P < 0.005). i, Avp-Cre mice receiving optical stimulation had a pronounced change in investigation behavior compared WT, regardless of retention interval (t(14) > 3.05, P < 0.01. No genotypic differences were observed in the absence of optical stimulation (t(14) = 1.65, P = 0.12). j, For the three-trial retroactive interference test, WT and Avp-Cre mice were exposed twice to the same OVX female similar to the two-trial SR test. However, 5 minutes into the 30-minute retention interval, subject mice were either undisturbed (non-interference condition, Non-Int) or exposed to a different female for 5 minutes as an interference trial (Int). k, WT mice (n = 9) decrease investigation behavior to a mouse encountered 30 min previously without optical stimulation (Non-Int, OFF) (ANOVA: genotype X trial F(1,14) > 37.62, P < 0.00005). Avp-Cre mice (n = 7) do not change investigation behavior to a mouse encountered in trial 1, if a second mouse is introduced during the retention period and in the absence of optical stimulation (Int, OFF). However, Avp-Cre, but not WT, mice receiving optical stimulation decrease investigation behavior when encountering a mouse for the second time, even with an interference trial (Int, T1-ON). l, The change in investigation occurs in WT mice without interference (Non-Int, OFF) and Avp-Cre mice receiving optical stimulation even after an interference trial (Int, T1-ON) (t(14) > 6.96, P < 0.00001). Interference trials limit change in investigation behavior in WT mice and Avp-Cre mice without optical stimulation (Int, OFF) (P > 0.23).
Figure 3Pharmacological antagonism of Avpr1b in the CA2 blocks optogenetic memory enhancement
a, The schematic illustrates AAV-ChR2-mCherry expression in AVP promoter-driven Cre (Avp-Cre) mice with intra-CA2 optical stimulation (emitting at a 465-nm wavelength from a LED light) and microinjections of the Avpr1b antagonist (SSR149415). b, Specifically, mice were injected with an adeno-associated virus containing a Cre-inducible ChR2-mCherry (AAV2-DIO-EF1α-hChR2(H134R)-mCherry) in the PVN and implanted with guide cannulae bilaterally in the CA2. The diagram illustrates the optical fiber (left; 11.5 mm shaft), 21-gauge guide cannula (bottom right; 8 mm pedestal, 3 mm metal cannula), and a dust cap outfitted with a ceramic sleeve threaded through and anchored with epoxy to the dust cap (top right). These modified dust caps and guide cannulae were designed to accommodate micro-injector needles for drug infusion as well as optical fibers. c, Before the acquisition trial, wild-type (WT) and Avp-Cre mice received 200 nl microinjections of a vehicle or an Avpr1b antagonist (SSR149415, 1 ng or 10 ng). Mice were then exposed to an unfamiliar OVX female for 5 minutes with optical stimulation (T1-ON) and re-exposed to the original female (Same ♀ condition) after a 2-hour retention interval. d, Avp-cre mice (blue, n = 8) receiving optical stimulation decreased investigation of a mouse encountered in trial 1 during trial 2 when concurrently treated with a drug vehicle and, to a lesser extent, 1 ng of SSR149415 but not a higher dose (10 ng) of this Avpr1b antagonist (ANOVA: genotype X drug X trial F(2, 42) = 10.98, P < 0.0005). Avp-Cre mice investigated the stimulus mouse during trial 2 significantly less than WT mice (grey, n = 8) but only when receiving the drug vehicle. e, Avp-Cre mice receiving optical stimulation displayed greater change in investigation compared to WT mice when concurrently receiving vehicle infusions, no change occurred when an Avpr1b antagonist (1 ng or 10 ng) was injected (ANOVA: genotype X drug F(2, 28) = 4.08, P < 0.05).